Biosimilars vs. Interchangeable Biological Products: FDA Fact Check
XTalks
FEBRUARY 8, 2021
As a subset of biosimilars, interchangeable biological products can be substituted for the reference product at the pharmacy level, without the input of the prescribing physician. What is an Interchangeable Biological Product? For example, ongoing patent litigation may dictate which indications are pursued for a biosimilar.
Let's personalize your content